HPV genotype distribution in older Danish women undergoing surgery due to cervical cancer

Acta Obstetricia et Gynecologica Scandinavica

Volumn 94, Issue 11, 2015, Pages 1262-1268

  Hammer, Anne ^a,b   Mejlgaard, Else ^a   Gravitt, Patti ^c   Høgdall, Estrid ^d   Christiansen, Pernille ^d   Steiniche, Torben ^a,b   Blaakær, Jan ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d Mental Health Center Glostrup   (Denmark)

Author keywords

Cervical cancer; genotypes; human papillomavirus; human papillomavirus vaccine; older women

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGED; ARTICLE; CANCER SURGERY; CROSS-SECTIONAL STUDY; DANISH CITIZEN; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; WART VIRUS; ADENOCARCINOMA; AGE; CARCINOMA, SQUAMOUS CELL; DENMARK; GENETICS; ISOLATION AND PURIFICATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REGISTER; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; VIROLOGY;

ADENOCARCINOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REGISTRIES; UTERINE CERVICAL NEOPLASMS;

EID: 84943583890     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12731     Document Type: Article

References (17)

1. Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, et al. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in europe. Int J Cancer. 2013;132:854-67.
2. Serrano B, Alemany L, Tous S, Bruni L, Clifford GM, Weiss T, et al. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agent Cancer. 2012;7:38.
3. de Sanjose S, Wheeler CM, Quint WG, Hunt WC, Joste NE, Alemany L, et al. Age-specific occurrence of HPV16- and HPV18-related cervical cancer. Cancer Epidemiol Biomarkers Prev. 2013;22:1313-8.
4. Joste NE, Ronnett BM, Hunt WC, Pearse A, Langsfeld E, Leete T, et al. Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer. Cancer Epidemiol Biomarkers Prev. 2015;24:230-40.
5. Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372:711-23.
6. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048-56.
7. Kirschner B, Junge J, Holl K, Rosenlund M, Collas de Souza S, Quint W, et al. HPV genotypes in invasive cervical cancer in danish women. Acta Obstet Gynecol Scand. 2013;92:1023-31.
8. Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WGV, Castle PE. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst. 2009;101:475-87.
9. Castle PE, Shaber R, LaMere BJ, Kinney W, Fetterma B, Poitras N, et al. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California. Cancer Epidemiol Biomarkers Prev. 2011;20:946-53.
10. Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P, et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res. 2008;68:307-13.
11. Alemany L, de Sanjose S, Tous S, Quint W, Vallejos C, Shin HR, et al. Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007. Int J Cancer. 2014;135:88-95.
12. Andersson S, Rylander E, Larson B, Sigurdardottir S, Backlund I, Sallstrom J, et al. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing. Oncol Rep. 2003;10:175-9.
13. Saito J, Hoshiai H, Noda K. Type of human papillomavirus and expression of p53 in elderly women with cervical cancer. Gynecol Obstet Invest. 2000;49:190-3.
14. Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices. Cancer Cytopathol. 2015;123:282-8.
15. Erickson BK, Zhang B, Straughn JM Jr. Screening behaviors and cultural barriers in women with newly diagnosed cervical cancer. J Low Genit Tract Dis. 2013;17:425-9.
16. Lombard I, Vincent-Salomon A, Validire P, Zafrani B, de la Rochefordiere A, Clough K, et al. Human papillomavirus genotype as a major determinant of the course of cervical cancer. J Clin Oncol. 1998;16:2613-9.
17. Baandrup L, Munk C, Andersen KK, Junge J, Iftner T, Kjaer SK. HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3. Gynecol Oncol. 2012;124:281-5.